Swiss National Bank G1 Therapeutics, Inc. Transaction History

Swiss National Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$2.57 - $8.16 $28,013 - $88,944	-10,900 Reduced 10.53%	92,600 $248,000
Q4 2022 Feb 08, 2023	BUY	$5.19 - $13.5 $537,165 - $1.4 Million	103,500 New	103,500 $562,000
Q2 2022 Aug 09, 2022	SELL	$4.04 - $8.51 $284,416 - $599,104	-70,400 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$7.6 - $11.02 $44,840 - $65,018	5,900 Added 9.15%	70,400 $535,000
Q4 2020 Feb 05, 2021	BUY	$10.99 - $20.4 $15,386 - $28,559	1,400 Added 2.22%	64,500 $1.16 Million
Q2 2020 Aug 05, 2020	BUY	$9.57 - $24.37 $115,797 - $294,877	12,100 Added 23.73%	63,100 $1.53 Million
Q1 2020 May 08, 2020	BUY	$9.07 - $26.32 $7,256 - $21,056	800 Added 1.59%	51,000 $562,000
Q4 2019 Feb 06, 2020	BUY	$20.54 - $31.0 $22,594 - $34,100	1,100 Added 2.24%	50,200 $1.33 Million
Q3 2019 Nov 12, 2019	BUY	$22.78 - $40.58 $15,946 - $28,406	700 Added 1.45%	49,100 $1.12 Million
Q2 2019 Aug 02, 2019	BUY	$16.03 - $31.1 $68,929 - $133,730	4,300 Added 9.75%	48,400 $1.48 Million
Q1 2019 May 10, 2019	BUY	$14.4 - $21.45 $82,080 - $122,265	5,700 Added 14.84%	44,100 $732,000
Q4 2018 Feb 13, 2019	BUY	$16.51 - $51.33 $21,463 - $66,729	1,300 Added 3.5%	38,400 $735,000
Q3 2018 Nov 08, 2018	BUY	$43.15 - $67.97 $69,040 - $108,752	1,600 Added 4.51%	37,100 $1.94 Million
Q1 2018 May 04, 2018	BUY	$19.05 - $41.76 $401,955 - $881,136	21,100 Added 146.53%	35,500 $1.32 Million
Q4 2017 Feb 07, 2018	BUY	$19.01 - $26.2 $273,744 - $377,280	14,400	14,400 $286,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.